Let's get an approval before fighting for how much they should charge. You need not recover all developmental costs in the first year. If in fact AD is first, it's probably the biggest application and worldwide acceptance shouldn't take all that long. How many patients should be estimated to benefit if applied worldwide, I'd think the number goes into the millions. Certainly not everyone will get it, but new patients will be added every year and existing patients will continue treatment, so revenue will be growing. Even if the annual cost was in the single digit thousands for the average patient the potential would be huge.
I've got to believe the news of an application being filed, regardless of the authority it's filed with, will be huge for the share price. No telling when, but it will happen.
Gary
Bullish